Infeccion por virus linfotrofico hunano/ de la laucemia de celulas t tipo I y II (HTLV-I y II)

Gonzalez Arroyave, Juan Carlos.
Med. U.P.B ; 18(1): 47-58, Abr.1999.
Artículo en Español | LILACS | ID: lil-619443

Documentos relacionados

  1. Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
  2. Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right direction.
  3. [National Questionnaire Survey on the Actual Use and Content Evaluation of the human T-cell leukemia virus type I (HTLV-1) -associated Myelopathy (HAM) Practice Guidelines 2019].
  4. Precise excision of HTLV-1 provirus with a designer-recombinase.
  5. Patient research priority setting partnership in human T-cell lymphotropic virus type I.
  6. Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
  7. Elderly people with human T-cell leukemia virus type 1-associated myelopathy present an early impairment in cognitive skills.
  8. HTLV, a multi organ oncovirus.
  9. HTLV-1 encephalitis.
  10. Establishment of a Cynomolgus Macaque Model of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Direct Inoculation of Adult T-Cell Leukemia Patient-Derived Cell Lines for HTLV-1 Infection.